Lyvecap ELITE

Yinka Davies, MD, is a Stanford-trained pediatric gastroenterologist who has been practicing for over 15 years. She is an adjunct clinical assistant professor at Stanford University School of Medicine involved in multiple clinical trials involving the human gut microbiome and how it relates to both disease and unwellness. She is passionate about educating on the importance of a balanced gut flora and demystifying the complexity of this system.

Professor Claudio De Simone, MD, PhD, is an internationally recognized pioneer in the field of intestinal microflora and the inventor of the proprietary probiotics used as the foundation for STRONG. After specializing in gastroenterology and immunology, he became the professor of infectious diseases and immunology at the University of L'Aquila and is a member of the American College of Gastroenterology. Over 25 years ago he developed the De Simone Formulation on which he has published 70+ peer reviewed articles. Additionally, he has authored over 200 published scientific articles, reviews, case reports, and book chapters.

Kenneth L. Cox, MD, is an emeritus professor of Pediatrics, Pediatric Gastroenterology, Hepatology, and Nutrition at Stanford University School of Medicine. He served as chief of the Division of Gastroenterology as well as associate chair of the Department of Pediatrics. In addition, he was the Senior Associate Dean for Pediatrics and Obstetrics at the School of Medicine, the Chief Medical Officer at the Lucile Packard Children’s Hospital and the Executive Director of the Pediatric and Obstetric Faculty Practice Organization. He also served as service chief of the Gastroenterology, Nutrition, and Hepatology Clinic at Lucile Packard Children’s Hospital. He has published 17 book chapters and 100+ peer-reviewed articles. His research interests include the role the gastrointestinal bacterial flora plays in autoimmune liver and intestinal disease.

Kari Nadeau, MD, is a respected professor at Stanford University School of Medicine. Among other leadership positions at Stanford, Dr. Nadeau is the Sr. Director of Clinical Research for the Division of Hospital Medicine. Additionally, she has served as a Food and Drug Administration (FDA) consultant.

For more than 30 years, she has devoted herself to understanding how environmental and genetic factors affect the risk of developing allergies and asthma, and the molecular mechanisms underlying the diseases. As one of the nation’s foremost experts in adult and pediatric allergy and asthma, her research is laying the groundwork for a variety of potential future therapies to prevent and cure allergies and asthma. To date, Dr. Nadeau has published over 200 peer-reviewed publications, and is a reviewer for NIH study sections and many high impact journals in basic science and clinical medicine.